CA1102345A - Soft anticholinergic agents exhibiting anti-secretory activity - Google Patents
Soft anticholinergic agents exhibiting anti-secretory activityInfo
- Publication number
- CA1102345A CA1102345A CA318,112A CA318112A CA1102345A CA 1102345 A CA1102345 A CA 1102345A CA 318112 A CA318112 A CA 318112A CA 1102345 A CA1102345 A CA 1102345A
- Authority
- CA
- Canada
- Prior art keywords
- process according
- group
- phenyl
- formula
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/90—Benzo [c] furans; Hydrogenated benzo [c] furans with an oxygen atom in position 1 and a nitrogen atom in position 3, or vice versa
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86121077A | 1977-12-16 | 1977-12-16 | |
US861,210 | 1977-12-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1102345A true CA1102345A (en) | 1981-06-02 |
Family
ID=25335183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA318,112A Expired CA1102345A (en) | 1977-12-16 | 1978-12-18 | Soft anticholinergic agents exhibiting anti-secretory activity |
Country Status (15)
Country | Link |
---|---|
JP (1) | JPS5498711A (es) |
AR (1) | AR222478A1 (es) |
AT (1) | AT366380B (es) |
AU (1) | AU531835B2 (es) |
CA (1) | CA1102345A (es) |
DE (1) | DE2854308A1 (es) |
DK (1) | DK534178A (es) |
ES (1) | ES476048A1 (es) |
FR (1) | FR2422624A1 (es) |
GB (1) | GB2010270B (es) |
IE (1) | IE48012B1 (es) |
IT (1) | IT1101735B (es) |
NL (1) | NL7812257A (es) |
NO (1) | NO148776C (es) |
SE (1) | SE436027B (es) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5962505A (en) * | 1998-08-31 | 1999-10-05 | Bobrove; Arthur M. | Method for treating hot flashes in humans |
US6433003B1 (en) | 1999-04-23 | 2002-08-13 | Arthur M. Bobrove | Method for treating hyperhidrosis in mammals |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3045055A1 (de) * | 1980-11-29 | 1982-07-01 | Celamerck Gmbh & Co Kg, 6507 Ingelheim | Heterocyclische verbindungen |
JPS5993075A (ja) * | 1982-11-18 | 1984-05-29 | Shionogi & Co Ltd | 1−フタリジル−5−フルオロウラシル誘導体の製造法 |
US5008111A (en) * | 1984-10-11 | 1991-04-16 | Schering Corporation | Physiological means of enhancing transdermal delivery of drugs |
US4824676A (en) * | 1984-10-11 | 1989-04-25 | Schering Corporation | Physiological means of enhancing transdermal delivery of drugs |
FR2703046B1 (fr) * | 1993-03-26 | 1995-05-05 | Poudres & Explosifs Ste Nale | Procédé de préparation d'oxalates et d'halogénoglyoxalates alpha- monohalogénés et nouveaux oxalates et halogénoglyoxalates alpha-monohalogénés . |
AUPN814496A0 (en) | 1996-02-19 | 1996-03-14 | Monash University | Dermal penetration enhancer |
AR044134A1 (es) * | 2003-05-02 | 2005-08-24 | Novartis Ag | Derivados de quinuclidina, metodo de preparacion y composiciones farmaceuticas. |
EA019214B1 (ru) | 2005-06-03 | 2014-02-28 | АКРУКС ДиДиЭс ПиТиУай ЭлТиДи | Способ лечения или профилактики заболеваний, вызванных дефицитом андрогенов у взрослых мужчин |
US20100222393A1 (en) * | 2005-12-30 | 2010-09-02 | Naresh Kumar | Muscarinic receptor antagonists |
PT2214643E (pt) | 2007-11-02 | 2014-05-26 | Acrux Dds Pty Ltd | Sistema de entrega transdérmica para hormonas e esteroides |
JP6621329B2 (ja) * | 2012-10-05 | 2019-12-18 | スファエラ ファーマ ピーティーイー リミテッド | 新規化合物、それらの合成及びそれらの使用 |
DE102013013397A1 (de) | 2013-08-13 | 2015-03-12 | Epinamics Gmbh | Aerosolspender für transdermal wirkende pharmazeutische Zusammensetzungen |
CN110041264A (zh) * | 2019-04-11 | 2019-07-23 | 贺州学院 | 一种金刚烷基咪唑类离子液体及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL101555C (es) * | 1955-03-19 | |||
BE798253A (nl) * | 1973-04-16 | 1973-10-16 | Bekaert Sa Nv | Zitmeubel |
US3998815A (en) * | 1974-06-24 | 1976-12-21 | Interx Research Corporation | 1-hydrocarbonoyloxymethyl-3-carbamoyl or 3-carboethoxy-pyridinium salts |
-
1978
- 1978-11-29 DK DK534178A patent/DK534178A/da not_active Application Discontinuation
- 1978-12-12 IT IT30735/78A patent/IT1101735B/it active
- 1978-12-15 NO NO784229A patent/NO148776C/no unknown
- 1978-12-15 DE DE19782854308 patent/DE2854308A1/de not_active Withdrawn
- 1978-12-15 AR AR274836A patent/AR222478A1/es active
- 1978-12-15 SE SE7812911A patent/SE436027B/sv unknown
- 1978-12-15 JP JP15601378A patent/JPS5498711A/ja active Pending
- 1978-12-15 ES ES476048A patent/ES476048A1/es not_active Expired
- 1978-12-18 AU AU42646/78A patent/AU531835B2/en not_active Expired
- 1978-12-18 FR FR7835596A patent/FR2422624A1/fr active Granted
- 1978-12-18 AT AT0901478A patent/AT366380B/de active
- 1978-12-18 GB GB7848850A patent/GB2010270B/en not_active Expired
- 1978-12-18 NL NL7812257A patent/NL7812257A/xx not_active Application Discontinuation
- 1978-12-18 IE IE2499/78A patent/IE48012B1/en unknown
- 1978-12-18 CA CA318,112A patent/CA1102345A/en not_active Expired
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5962505A (en) * | 1998-08-31 | 1999-10-05 | Bobrove; Arthur M. | Method for treating hot flashes in humans |
US6433003B1 (en) | 1999-04-23 | 2002-08-13 | Arthur M. Bobrove | Method for treating hyperhidrosis in mammals |
Also Published As
Publication number | Publication date |
---|---|
SE436027B (sv) | 1984-11-05 |
NO148776B (no) | 1983-09-05 |
JPS5498711A (en) | 1979-08-03 |
AU4264678A (en) | 1979-06-21 |
ES476048A1 (es) | 1979-11-01 |
DE2854308A1 (de) | 1979-06-21 |
FR2422624B1 (es) | 1983-10-14 |
AT366380B (de) | 1982-04-13 |
AU531835B2 (en) | 1983-09-08 |
FR2422624A1 (fr) | 1979-11-09 |
IE48012B1 (en) | 1984-09-05 |
NO148776C (no) | 1983-12-14 |
ATA901478A (de) | 1981-08-15 |
SE7812911L (sv) | 1979-06-17 |
NL7812257A (nl) | 1979-06-19 |
NO784229L (no) | 1979-06-19 |
DK534178A (da) | 1979-06-17 |
IT7830735A0 (it) | 1978-12-12 |
IT1101735B (it) | 1985-10-07 |
GB2010270A (en) | 1979-06-27 |
GB2010270B (en) | 1982-10-20 |
IE782499L (en) | 1979-06-16 |
AR222478A1 (es) | 1981-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1102345A (en) | Soft anticholinergic agents exhibiting anti-secretory activity | |
ES2220927T3 (es) | Derivados de dc-89. | |
RU2073677C1 (ru) | Сложные эфиры тиенилкарбоновой кислоты и аминоспиртов, способ их получения и фармацевтическая композиция, обладающая антихолинергической активностью | |
DE3514076C2 (es) | ||
CA2078264A1 (en) | Substituted derivatives of piperizinylcamphorsulfonyl oxytocin antagonists | |
DE3236065A1 (de) | Dioximinocephalosporine | |
US6307053B1 (en) | Process for preparing imidacloprid | |
DE2916140A1 (de) | 1,3-diphenyl-2-iminoimidazolidine und 1,3-diphenyl-2-iminohexahydropyrimidine, verfahren zu ihrer herstellung und solche enthaltende arzneimittel | |
US3349082A (en) | Mannich bases of rifamycin sv | |
DE3005888A1 (de) | 3-phosphonocephalosporansaeure- derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel | |
JPS6372687A (ja) | (ベンゾフラン−2−イル)イミダゾ−ル化合物、その製造法及びそれを含有する医薬組成物 | |
CS246074B2 (en) | Method of n-iminopyridinium's betaines preparation | |
KR0178957B1 (ko) | 페넴 화합물 | |
DE2857816C2 (de) | 7ß-(substituierte-Isothiazol)thioacetamido-7-methoxy(alkylsubstituierte-tetraz olyl)thiomethyl-Δ↑3↑-cephem-4-carbonsäuren, Verfahren zu ihrer Herstellung und deren Verwendung | |
US2759943A (en) | Derivatives of 2-n-methyl-1, 2, 3, 4-tetrahydro-gamma-carbolines | |
US3725419A (en) | Quinuclidylalkyl esters | |
DD210054A5 (de) | Verfahren zur herstellung neuer derivate des cephalosporin | |
HU197843B (en) | Process for producing pharmaceutical compositions comprising 2-alkoxy-n-(1-azabicyclo/2.2.2/oct-3-yl)-benzamide-n-oxide derivatives | |
KR0177844B1 (ko) | 항균성 페넴화합물 | |
US3133067A (en) | 1-monocarbocyclic aryl-4-thiocarbam-ylpiperazines and intermediates and processes therefor | |
US3322768A (en) | Aralkyl piperazines and salts thereof | |
US4477449A (en) | Certain 1,8-naphthyridine compounds useful as antibacterial agents | |
KR880001105B1 (ko) | 1-벤질-4-[4-(2-피리미디닐아미노)벤질]-2,3-디옥소피페라진 유도체의 제조방법 | |
AT391695B (de) | Neue verbindungen, ihre herstellung und diese enthaltende pharmazeutische zubereitungen | |
US3528968A (en) | Heterocyclic substituted imidazoline hydrazones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKEX | Expiry |